“Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq””. 2026. Journal of Cancer Research Updates 15 (1): 150-55. https://doi.org/10.30683/1929-2279.2026.15.13.